---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-028803"
form_type: "8-K"
ticker: "ANVS"
cik: "0001477845"
company_name: "Annovis Bio, Inc."
filed_at: "2025-03-27T23:59:59+00:00"
generated_at: "2026-05-24T03:51:01.526011+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Annovis Bio receives NYSE delisting notice, market cap ~$37.9M, equity $9.3M; CFO Fricker departs

## Summary
- NYSE notice: 30-day avg mkt cap ~$37.9M, equity $9.3M at Dec 31, 2024, both below $50M thresholds.
- Company has 45 days to submit compliance plan; NYSE may grant up to 18-month cure period; symbol gets '.BC' indicator.
- No immediate impact on stock listing, business operations, or SEC reporting obligations.
- Interim CFO William Fricker departs March 27 by mutual agreement; no dispute over accounting.
- CEO Maria Maccecchini assumes interim principal financial officer role.

## SEC filing metadata
- accession: 0001104659-25-028803
- form_type: 8-K
- ticker: ANVS
- cik: 0001477845
- company_name: Annovis Bio, Inc.
- filed_at: 2025-03-27T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01, 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1477845/000110465925028803/0001104659-25-028803-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1477845/000110465925028803/tm2510633d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-028803
- JSON: https://secwatch.observer/filing/0001104659-25-028803.json
- Plain text: https://secwatch.observer/filing/0001104659-25-028803.txt

## Key facts
- Executive change
  William Fricker departed as Interim Chief Financial Officer at Annovis Bio, Inc..
  - Action: will no longer serve
  - Role: Interim Chief Financial Officer
  source text: On March 27, 2025, by mutual agreement, Mr. Fricker will no longer serve as interim Chief Financial Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1477845/000110465925028803/0001104659-25-028803-index.htm
- Executive change
  Maria Maccecchini was appointed as Principal Financial Officer on an interim basis at Annovis Bio, Inc..
  - Action: appointed
  - Role: Principal Financial Officer on an interim basis
  source text: Maria Maccecchini will continue to serve as principal financial officer on an interim basis.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1477845/000110465925028803/0001104659-25-028803-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.